How to Navigate Ecosystem Connect NEW Distinguished Investigators 
Global Conferences RLT Education RLT Components Sponsors Trial Stats
Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Contact XCancer
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.com[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone PET Imaging In Patients Advanced Breast Cancer
Description:
The purpose of this study is to see whether 18F-FDHT PET/MRI scans are an effective way of identifying AR-positive breast cancer.
Sponsor:
Memorial Sloan Kettering Cancer Center
Phase:
Early Phase 1
Contacts:
Maxine Jochelson, MD (Principal Investigator)jochelsm@mskcc.org
646-888-4507
Hedvig Hricak, MDhricakh@mskcc.org
646-888-2211
Government Study Link:
NCT06145399 - Click here to see study onClinicalTrials.gov
Share your feedback
Help us improve your experience